Jeong-Yeon Seo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeong-Yeon Seo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Do Kyung Kim
Professor, Institute of Dental Science, Chosun University, Gwangju, Republic of Korea
4 shared publications - HyangI Lim
Master’s Degree, Institute of Dental Science, Chosun University, Jeonnam-Gwangju, Republic of Korea
4 shared publications - Jae-Sung Kim
Professor, Institute of Dental Science, Chosun University, Gwangju, Republic of Korea
4 shared publications - Kyeong-Rok Kang
Postdoc Research Assistant, Institute of Dental Science, Chosun University, Jeonnam-Gwangju, Republic of Korea
4 shared publications - Hong Sung Chun
Department of Biomedical Science, Chosun University
2 shared publications - Tae-Hyeon Kim
Division of Animal Science, Gyeongsang National University, Jinju 52828, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 30 September 2024
- Published by The Oral Biology Research Institute at Chosum University in Oral Biology Research
- Vol. 48 (3) , 82-88
Apoptotic effect of betulinic acid in FaDu human head and neck squamous cell carcinomas
Kyeong-Rok Kang, Jae-Sung Kim, Jeong-Yeon Seo, HyangI Lim, and Do Kyung Kim. Oral Biol Res 2024;48:82-8. https://doi.org/10.21851/obr.48.03.202409.82
- 30 September 2024
- Published by The Oral Biology Research Institute at Chosum University in Oral Biology Research
- Vol. 48 (3) , 82-88
Open AccessApoptotic effect of betulinic acid in FaDu human head and neck squamous cell carcinomas
Kyeong-Rok Kang, Jae-Sung Kim, Jeong-Yeon Seo, HyangI Lim, and Do Kyung Kim. Oral Biol Res 2024;48:82-8. https://doi.org/10.21851/obr.48.03.202409.82
- Open Access
- 31 December 2023
- Published by The Oral Biology Research Institute at Chosum University in Oral Biology Research
- Vol. 47 (4) , 132-139
Apoptotic effects of hyperoside on FaDu human pharyngeal carcinoma cells
Kyeong-Rok Kang, Jeong-Yeon Seo, HyangI Lim, Jae-Sung Kim, and Do Kyung Kim. Oral Biol Res 2023;47:132-9. https://doi.org/10.21851/obr.47.04.202312.132
- 31 December 2023
- Published by The Oral Biology Research Institute at Chosum University in Oral Biology Research
- Vol. 47 (4) , 132-139
Open AccessApoptotic effects of hyperoside on FaDu human pharyngeal carcinoma cells
Kyeong-Rok Kang, Jeong-Yeon Seo, HyangI Lim, Jae-Sung Kim, and Do Kyung Kim. Oral Biol Res 2023;47:132-9. https://doi.org/10.21851/obr.47.04.202312.132
- Open Access
- 10 March 2023
- Published by Elsevier in Molecules and Cells
- Vol. 46 (4) , 245-255
7α,25-Dihydroxycholesterol-Induced Oxiapoptophagic Chondrocyte Death via the Modulation of p53-Akt-mTOR Axis in Osteoarthritis Pathogenesis
Jeong-Yeon Seo, Tae-Hyeon Kim, Kyeong-Rok Kang, HyangI Lim, Moon-Chang Choi, Do Kyung Kim, Hong Sung Chun, Heung-Joong Kim, Sun-Kyoung Yu, and Jae-Sung Kim. Mol. Cells 2023;46:245-55. https://doi.org/10.14348/molcells.2023.2149
- 10 March 2023
- Published by Elsevier in Molecules and Cells
- Vol. 46 (4) , 245-255
Open Access7α,25-Dihydroxycholesterol-Induced Oxiapoptophagic Chondrocyte Death via the Modulation of p53-Akt-mTOR Axis in Osteoarthritis Pathogenesis
Jeong-Yeon Seo, Tae-Hyeon Kim, Kyeong-Rok Kang, HyangI Lim, Moon-Chang Choi, Do Kyung Kim, Hong Sung Chun, Heung-Joong Kim, Sun-Kyoung Yu, and Jae-Sung Kim. Mol. Cells 2023;46:245-55. https://doi.org/10.14348/molcells.2023.2149
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Acteoside Counteracts Interleukin‐1β‐Induced Catabolic Processes through the Modulation of Mitogen‐Activated Protein Kinases and the NFκB Cellular Signaling Pathway
Osteoarthritis (OA) is the most common degenerative joint disease with chronic joint pain caused by progressive degeneration of articular cartilage at synovial joints. Acteoside, a caffeoylphenylethanoid glycoside, has various biological activities such as antimicrobial, anti‐inflammatory, anticancer, antioxidative, cytoprotective, and neuroprotective effect. Further, oral administration of acteoside at high dosage does not cause genotoxicity. Therefore, the aim of present study is to verify the anticatabolic effects of acteoside against osteoarthritis and its anticatabolic signaling pathway. Acteoside did not decrease the viabilities of mouse fibroblast L929 cells used as normal cells and primary rat chondrocytes. Acteoside counteracted the IL‐1β‐induced proteoglycan loss in the chondrocytes and articular cartilage through suppressing the expression and activation of cartilage‐degrading enzyme such as matrix metalloproteinase‐ (MMP‐) 13, MMP‐1, and MMP‐3. Furthermore, acteoside suppressed the expression of inflammatory mediators such as inducible nitric oxide synthase, cyclooxygenase‐2, nitric oxide, and prostaglandin E2 in the primary rat chondrocytes treated with IL‐1β. Subsequently, the expression of proinflammatory cytokines was decreased by acteoside in the primary rat chondrocytes treated with IL‐1β. Moreover, acteoside suppressed not only the phosphorylation of mitogen‐activated protein kinases in primary rat chondrocytes treated with IL‐1β but also the translocation of NFκB from the cytosol to the nucleus through suppression of its phosphorylation. Oral administration of 5 and 10 mg/kg acteoside attenuated the progressive degeneration of articular cartilage in the osteoarthritic mouse model generated by destabilization of the medial meniscus. Our findings indicate that acteoside is a promising potential anticatabolic agent or supplement to attenuate or prevent progressive degeneration of articular cartilage.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessActeoside Counteracts Interleukin‐1β‐Induced Catabolic Processes through the Modulation of Mitogen‐Activated Protein Kinases and the NFκB Cellular Signaling Pathway
Osteoarthritis (OA) is the most common degenerative joint disease with chronic joint pain caused by progressive degeneration of articular cartilage at synovial joints. Acteoside, a caffeoylphenylethanoid glycoside, has various biological activities such as antimicrobial, anti‐inflammatory, anticancer, antioxidative, cytoprotective, and neuroprotective effect. Further, oral administration of acteoside at high dosage does not cause genotoxicity. Therefore, the aim of present study is to verify the anticatabolic effects of acteoside against osteoarthritis and its anticatabolic signaling pathway. Acteoside did not decrease the viabilities of mouse fibroblast L929 cells used as normal cells and primary rat chondrocytes. Acteoside counteracted the IL‐1β‐induced proteoglycan loss in the chondrocytes and articular cartilage through suppressing the expression and activation of cartilage‐degrading enzyme such as matrix metalloproteinase‐ (MMP‐) 13, MMP‐1, and MMP‐3. Furthermore, acteoside suppressed the expression of inflammatory mediators such as inducible nitric oxide synthase, cyclooxygenase‐2, nitric oxide, and prostaglandin E2 in the primary rat chondrocytes treated with IL‐1β. Subsequently, the expression of proinflammatory cytokines was decreased by acteoside in the primary rat chondrocytes treated with IL‐1β. Moreover, acteoside suppressed not only the phosphorylation of mitogen‐activated protein kinases in primary rat chondrocytes treated with IL‐1β but also the translocation of NFκB from the cytosol to the nucleus through suppression of its phosphorylation. Oral administration of 5 and 10 mg/kg acteoside attenuated the progressive degeneration of articular cartilage in the osteoarthritic mouse model generated by destabilization of the medial meniscus. Our findings indicate that acteoside is a promising potential anticatabolic agent or supplement to attenuate or prevent progressive degeneration of articular cartilage.